GSD NovaType Select E484K SARS-CoV-2 (1x96)

Real-time RT-PCR assay designed for the qualitative detection of the SARS-CoV-2 S gene mutation E484K.

The assay is designed to be used in combination with the GSD NovaType Select Base SARS-CoV-2 RT-PCR.

Sample material should be genomic RNA extracted from human upper respiratory (nasal wash/swab, nasopharyngeal wash/swab, oropharyngeal swab) specimen types that have previously tested positive for SARS-CoV-2 RNA by diagnostic RT-PCR methods e.g. GSD NovaPrime^® SARS-CoV-2 (COVID-19).

Further Select assays are available. The NovaType Select assay family detects the following mutations: K417N, K417T, L452R, T478K, E484K, P681R, P618H.

Key Features and benefits of the GSD NovaType Select family

• • Customized assay set-up
• • Confirmatory tests for detection of new emerging mutations
• • Parallel discrimination of most relevant mutations in S gene
• • Offered as combination of basis kit including the enzyme mastermix and a range of mutation specific sets including primer, probes and controls
• • Specimen types: nasal lavage/smear, nasopharyngeal lavage/smear, oropharyngeal swab
• • Validated PCR platforms: AriaDx^TM and AriaMx^TM (Agilent Technologies)
• • RUO